Literature DB >> 8017975

Leucocyte adhesion deficiency syndromes.

N Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8017975      PMCID： PMC1029843          DOI： 10.1136/adc.70.5.450-b

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  7 in total

1.  The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.

Authors:  L E Bradbury; G S Kansas; S Levy; R L Evans; T F Tedder
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

2.  Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency.

Authors:  A Etzioni; M Frydman; S Pollack; I Avidor; M L Phillips; J C Paulson; R Gershoni-Baruch
Journal:  N Engl J Med       Date:  1992-12-17       Impact factor: 91.245

3.  Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

Authors:  C Berlin; E L Berg; M J Briskin; D P Andrew; P J Kilshaw; B Holzmann; I L Weissman; A Hamann; E C Butcher
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

4.  Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue.

Authors:  S Suzuki; K Sano; H Tanihara
Journal:  Cell Regul       Date:  1991-04

Review 5.  Leucocyte adhesion deficiency.

Authors:  M H el Habbal; S Strobel
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

6.  Cloning and expression of mouse integrin beta p(beta 7): a functional role in Peyer's patch-specific lymphocyte homing.

Authors:  M C Hu; D T Crowe; I L Weissman; B Holzmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

7.  Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes.

Authors:  J Fawcett; C L Holness; L A Needham; H Turley; K C Gatter; D Y Mason; D L Simmons
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.